Doreen Ma

684 total citations
9 papers, 571 citations indexed

About

Doreen Ma is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Doreen Ma has authored 9 papers receiving a total of 571 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Oncology and 2 papers in Pharmacology. Recurrent topics in Doreen Ma's work include Colorectal Cancer Treatments and Studies (4 papers), Fungal and yeast genetics research (3 papers) and Fungal Biology and Applications (2 papers). Doreen Ma is often cited by papers focused on Colorectal Cancer Treatments and Studies (4 papers), Fungal and yeast genetics research (3 papers) and Fungal Biology and Applications (2 papers). Doreen Ma collaborates with scholars based in United States, Germany and Australia. Doreen Ma's co-authors include Henrik Dohlman, Jeremy Thorner, William E. Courchesne, Jianping Song, Clet Niyikiza, Olaf Oberschmidt, Ulrike Eismann, Christopher Kaiser, Victor Chen and Hartmut M. Hanauske‐Abel and has published in prestigious journals such as Molecular and Cellular Biology, Clinical Cancer Research and International Journal of Cancer.

In The Last Decade

Doreen Ma

9 papers receiving 560 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Doreen Ma United States 8 394 126 97 71 54 9 571
Yoshie Fujiwara Japan 13 624 1.6× 118 0.9× 49 0.5× 55 0.8× 16 0.3× 21 804
Christian V. Recktenwald Germany 17 373 0.9× 85 0.7× 105 1.1× 55 0.8× 44 0.8× 29 634
Shinji Mima Japan 15 434 1.1× 123 1.0× 53 0.5× 73 1.0× 16 0.3× 30 697
Gabriel B. Kalmar Canada 13 503 1.3× 92 0.7× 30 0.3× 144 2.0× 18 0.3× 22 656
Jianli Sang China 14 361 0.9× 83 0.7× 37 0.4× 61 0.9× 11 0.2× 37 554
Janel K. Warmka United States 9 328 0.8× 96 0.8× 28 0.3× 54 0.8× 22 0.4× 10 464
Yuki Ishii Japan 17 524 1.3× 139 1.1× 44 0.5× 40 0.6× 10 0.2× 29 703
Siyuan Su China 14 358 0.9× 75 0.6× 34 0.4× 87 1.2× 11 0.2× 18 532
Etsuo Nakamura Japan 11 303 0.8× 99 0.8× 16 0.2× 58 0.8× 45 0.8× 17 509
Katrin Altmann Germany 6 530 1.3× 83 0.7× 24 0.2× 57 0.8× 57 1.1× 8 598

Countries citing papers authored by Doreen Ma

Since Specialization
Citations

This map shows the geographic impact of Doreen Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Doreen Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Doreen Ma more than expected).

Fields of papers citing papers by Doreen Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Doreen Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Doreen Ma. The network helps show where Doreen Ma may publish in the future.

Co-authorship network of co-authors of Doreen Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Doreen Ma. A scholar is included among the top collaborators of Doreen Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Doreen Ma. Doreen Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Gustavsson, Bengt, Christopher Kaiser, Göran Carlsson, et al.. (2008). Molecular determinants of efficacy for 5‐FU‐based treatments in advanced colorectal cancer: mRNA expression for 18 chemotherapy‐related genes. International Journal of Cancer. 124(5). 1220–1226. 33 indexed citations
2.
Hanauske, Axel-Rainer, Ulrike Eismann, Olaf Oberschmidt, et al.. (2007). Correlations of mRNA expression and in vitro chemosensitivity to enzastaurin in freshly explanted human tumor cells. Investigational New Drugs. 26(3). 215–222. 3 indexed citations
4.
Hanauske, Axel-Rainer, Ulrike Eismann, Olaf Oberschmidt, et al.. (2007). In vitro chemosensitivity of freshly explanted tumor cells to pemetrexed is correlated with target gene expression. Investigational New Drugs. 25(5). 417–423. 74 indexed citations
5.
Llombart‐Cussac, Antonio, Miguel Martín, Nadia Harbeck, et al.. (2007). A Randomized, Double-Blind, Phase II Study of Two Doses of Pemetrexed as First-Line Chemotherapy for Advanced Breast Cancer. Clinical Cancer Research. 13(12). 3652–3659. 25 indexed citations
6.
Lahn, Michael, Su Chen, Shuyu Li, et al.. (2004). Expression Levels of Protein Kinase C-α in Non–Small-Cell Lung Cancer. Clinical Lung Cancer. 6(3). 184–189. 34 indexed citations
7.
Huss, Karen, Li-Chun Chio, Margaret Shaw, et al.. (2004). Discovery of Cercosporamide, a Known Antifungal Natural Product, as a Selective Pkc1 Kinase Inhibitor through High-Throughput Screening. Eukaryotic Cell. 3(4). 932–943. 84 indexed citations
8.
Ma, Doreen. (2001). Applications of yeast in drug discovery. Birkhäuser Basel eBooks. 57. 117–162. 19 indexed citations
9.
Dohlman, Henrik, Jianping Song, Doreen Ma, William E. Courchesne, & Jeremy Thorner. (1996). Sst2, a Negative Regulator of Pheromone Signaling in the Yeast Saccharomyces cerevisiae: Expression, Localization, and Genetic Interaction and Physical Association with Gpa1 (the G-Protein α Subunit). Molecular and Cellular Biology. 16(9). 5194–5209. 283 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026